Publications

Use the search tool below to browse peer-reviewed published articles on or related to Jazz's approved and investigational products. Please note, publications related to Jazz's approved product may contain information about dosing or use of a Jazz product that is different from the approved use(s). Jazz does not recommend the use of any of its products in any manner that listed in the product Prescribing Information, which is displayed as part of this search tool. Publications on Jazz's investigational products are provided for information only. Under no circumstances does Jazz promote use of a product without a licensed indication. If you have any questions about information in a publication or wish to access a publication not listed below, please contact Jazz Medical Information via the link below.

Product

Clear selection Defitelio® (defibrotide) Epidiolex® (cannabidiol) Rylaze® (asparaginase erwinia chrysanthemi (recombinant) rywn) injection Vyxeos® (daunorubicin and cytarabine) Xywav® (calcium, magnesium, potassium, and sodium oxybates) oral solution, CIII Ziihera® (zanidatamab) Zepzelca® (lurbinectedin)

Filter by keywords

Publication

Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary.

Published: September 27, 2023

Authors: Russell Rosenberg, Rogelio Braceras, Wayne Macfadden et al.

Publication

Long-Term Treatment of Narcolepsy and Idiopathic Hypersomnia with Low-Sodium Oxybate.

Published: August 19, 2023

Authors: Logan D Schneider, Anne Marie Morse, Michael J Strunc et al.

Publication

Impairment in Functioning and Quality of Life in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE).

Published: August 02, 2023

Authors: Joanne Stevens, Logan D Schneider, Aatif M Husain et al.

Publication

Effectiveness and tolerability in people with narcolepsy transitioning from sodium oxybate to low-sodium oxybate: Data from the real-world TENOR study.

Published: June 19, 2023

Authors: Charles J Bae, Phyllis C Zee, Eileen B Leary et al.

Publication

Efficacy of cannabidiol in convulsive and nonconvulsive seizure types associated with treatment-resistant epilepsies in the Expanded Access Program.

Published: June 15, 2023

Authors: Robert J Flamini, Anne M Comi, E Martina Bebin et al.

Publication

Effects of Cannabidiol, Hypothermia, and Their Combination in Newborn Rats with Hypoxic-Ischemic Encephalopathy.

Published: May 05, 2023

Authors: Francisco J Alvarez, Antonia A Alvarez, José J Rodríguez et al.

Publication

Long-Term Safety and Tolerability During a Clinical Trial and Open-Label Extension of Low-Sodium Oxybate in Participants with Narcolepsy with Cataplexy.

Published: March 22, 2023

Authors: Richard K Bogan, Nancy Foldvary-Schaefer, Roman Skowronski et al.

Publication

Population pharmacokinetics of intramuscular recombinant Erwinia chrysanthemi asparaginase (JZP458) in patients with acute lymphoblastic leukemia.

Published: March 16, 2023

Authors: Tong Lin, Tajhia Whigham, Indrasiri Fernando et al.

Publication

Symptom Severity and Treatment Satisfaction in Patients with Idiopathic Hypersomnia: The Real World Idiopathic Hypersomnia Outcomes Study (ARISE).

Published: March 11, 2023

Authors: Logan Douglas Schneider, Joanne Stevens, Aatif M Husain et al.

Publication

Update on the treatment of idiopathic hypersomnia: Progress, challenges, and expert opinion.

Published: February 25, 2023

Authors: Isabelle Arnulf, Robert Thomas, Asim Roy et al.

Disclaimer

This AI model is continuing to learn and its responses are based on learned data patterns. It should not replace professional judgment. Please verify the information before use, and feedback is welcome to improve its accuracy.

Please do not include personal or confidential information in your searches. For information on how to report an adverse event or product complaint for a Jazz product, please visit: https://www.jazzpharma.com/medicines/drug-safety/.